Research indicates that extended PSMA therapy is safe and effective for patients with prostate cancer.

Published Date: 05 Jun 2024

For patients with metastatic castration-resistant prostate cancer, extended prostate-specific membrane antigen (PSMA)-targeted radiopharmaceutical therapy (177Lu-PSMA) beyond six cycles is an efficient and well-tolerated treatment.

Read Full News

Latest News

Prolonged Screen Time Linked to Sleep Issues in Preschoolers

Preschool-aged children exposed to screens for extended daily periods face elevated prevalence of sleep disturbances.

US Mental Health Treatment Rates Rise But Gaps Persist

Treatment rates for US adults with psychiatric disorders are modestly higher than in previous decades, but only a third receive minimally adequate care, new research shows.

Cognitive Bias Modification App Fosters Alcohol Avoidance

An Australian-designed smartphone app uses personalized cognitive bias modification to help users reduce or avoid alcohol consumption.

Schizophrenia: Nighttime Light Tied to Metabolic Dysfunction

Higher vs lower nighttime light exposure is associated with increased risk for obesity, hypertension, and dyslipidemia in patients with schizophrenia, a study suggests.

Testicular Mass Serendipitously Found 12 Years After Prostate Cancer Dx

Consistently low PSA levels failed to signal metastasis

A Sinister Etiology for Shoulder Pain

Patient presented with what was assumed to be rotator cuff injury

Todays Updates

Freeman’s Lobotomy to Deep Brain Stimulation: What Changed?

The history of lobotomy shows the risks for limited evidence and oversight, while modern approaches emphasize targeted treatment, informed consent, and rigorous evaluation.

Wide Variation Seen in Lung Screening False-Positive Rates

US radiologists vary substantially in their reading of low-dose CT lung cancer screens, highlighting a need for measures to help standardize interpretation.

AVD Chemo Regimen Shows Promise in Older Patients With HL

Researchers compare first-line chemotherapy regimens in older patients with classical Hodgkin lymphoma to assess whether AVD is associated with better outcomes in routine care.

Do High-Risk Features of Prostate Cancer Boost HT Benefit?

Researchers analyze individual patient data from five randomized phase 3 trials comparing PORT alone vs PORT plus hormone therapy in patients with recurrent prostate cancer.

How Low Does PSA Need to Go in Metastatic Prostate Cancer?

A new real-world analysis helps clarify the most informative prognostic PSA benchmark in men with metastatic castration-sensitive prostate cancer.

Tissue-Free ctDNA Strongly Prognostic of Recurrence in TNBC

Tissue-free ctDNA may be comparable to tumor-informed assays in detecting molecular residual disease.

Todays Updates

Freeman’s Lobotomy to Deep Brain Stimulation: What Changed?

The history of lobotomy shows the risks for limited evidence and oversight, while modern approaches emphasize targeted treatment, informed consent, and rigorous evaluation.

Wide Variation Seen in Lung Screening False-Positive Rates

US radiologists vary substantially in their reading of low-dose CT lung cancer screens, highlighting a need for measures to help standardize interpretation.

AVD Chemo Regimen Shows Promise in Older Patients With HL

Researchers compare first-line chemotherapy regimens in older patients with classical Hodgkin lymphoma to assess whether AVD is associated with better outcomes in routine care.

Do High-Risk Features of Prostate Cancer Boost HT Benefit?

Researchers analyze individual patient data from five randomized phase 3 trials comparing PORT alone vs PORT plus hormone therapy in patients with recurrent prostate cancer.

How Low Does PSA Need to Go in Metastatic Prostate Cancer?

A new real-world analysis helps clarify the most informative prognostic PSA benchmark in men with metastatic castration-sensitive prostate cancer.

Tissue-Free ctDNA Strongly Prognostic of Recurrence in TNBC

Tissue-free ctDNA may be comparable to tumor-informed assays in detecting molecular residual disease.

Latest News

Preschool-aged children exposed to screens for extended daily periods face elevated prevalence of sleep disturbances.

Treatment rates for US adults with psychiatric disorders are modestly higher than in previous decades, but only a third receive minimally adequate care, new research shows.

An Australian-designed smartphone app uses personalized cognitive bias modification to help users reduce or avoid alcohol consumption.

Higher vs lower nighttime light exposure is associated with increased risk for obesity, hypertension, and dyslipidemia in patients with schizophrenia, a study suggests.

Consistently low PSA levels failed to signal metastasis

Patient presented with what was assumed to be rotator cuff injury

News All Time

Tennessee Pharmacies Sell Potent Ivermectin Pushed by Anti-Vaccine Doctor

"I've taken bucketloads of this stuff," says Denise Sibley

More Americans Are Surviving Cancer. But the Mental Health Challenges Can Persist.

A look at the "silent" impacts of cancer

Multicomponent Test Tops PSA for Clinically Significant Prostate Cancers

Blood-based biomarker test had similar false-positive rate as PSA, while reducing false negatives

More Data Back Teclistamab for Autoimmune Disease

Another case series shows most patients improved markedly after failing everything else

'The Pitt' Actor's Cancer Diagnosis; New HHS Research Plans; Madonna Reveals Injury

Health news and commentary gathered by MedPage Today staff

Nature Retracts Cancer Study Suggesting Treatment Is Better Earlier in the Day

Editors "no longer have confidence in the integrity of the results"

Long-Term CAR-T Results in Lymphoma Confirm Early Promise

Lymphoma-free survival exceeding 5 years in early recipients of the cellular therapy

I Watched My Friend Choose Death. Physician-Assisted Suicide Needs More Guardrails.

And the fundamental question remains of whether doctors should be involved at all

Scream, It's Good for You; Release the Cancer Pigeons; Talk of Chemo Rationing

News, features, and commentary about cancer-related issues

A Cancer Patient's Cats Inspired a Push for Pets in Hospice Wards

The presence of a beloved pet can ease the pain of terminally ill patients, says one doctor

Patellar Resurfacing in Total Knee Replacement; Patient Messaging Trends

Also in TTHealthWatch: tranexamic acid in routine surgery

Study Homes In on Simpler Lung Cancer Screening Criteria

Researchers find benefits, trade-offs using various levels of smoking duration alone

Orca-T Approved to Prevent GVHD After Stem Cell Transplant for Blood Cancers

Regulatory T cell-based immunotherapy approved for use in matched-donor HSCTs

Smoker's Painless Skin Nodules Flag a Fatal Diagnosis

Skin metastasis was the first sign for the otherwise asymptomatic patient

Where Did This Very Painful Gluteal Mass Come From?

High clinical suspicion, low threshold for biopsy key to diagnosis

Why Are These Bones and Teeth Where They Shouldn't Be?

Discovery in 31-year-old woman made after she came to the ER with mild abdominal pain

Recommended News For You

Traveling to Die: The Latest Form of Medical Tourism

Treating Depression: Crucial for Recovery From Fibromyalgia

Housing aid linked to lower medical financial hardship among US renters with cancer

A small rise in cancer was observed following the 1986 Chernobyl accident.

Prostate cancer screening program beneficial in top decile of polygenic risk score

Chemoimmunotherapy Boosts Head and Neck Cancer Response

ASCO Future Focus: Metastatic Breast Cancer: Future Focus from the American Society of Clinical Oncology

Recommended Articles For You

Mastering Oncology RCM: Reducing Errors, Denials & Improving Billing Efficiency 

AI in Genomics: Decoding the Human Genome for Cancer Treatment 

Gene Signatures and Their Implications in Oncology: Decoding the Blueprint for Personalized Cancer Treatment 

Chloride Test in HCC: Diagnostic Utility, Prognostic Role, and Emerging Insights 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Drugmaker Pulls Trodelvy's Bladder Cancer Approval

2.

Prostate cancer therapies: AI-based image analysis detects early organ damage

3.

Limited Benefit from New Drugs; Significant Increase in Drug Prices; AI Boost for Mammo Results.

4.

June 20, 2023, Health Bulletin No. 12.

5.

Thriving while surviving: Understanding the social needs of cancer survivors

1.

A Mural of Thrombus: Unlocking the Power of Art to Combat Cardiovascular Disease

2.

Strategic Concepts in Hematology for Modern Medicine

3.

Metabolic Plasticity in the Progression of Solid Tumors

4.

Unleashing Precision Medicine: CRISPR-Cas9 Gene Editing in Hematopoietic Stem Cells

5.

Understanding Drug-Induced Cardiotoxicity: Mechanisms, Impact, and Future Directions

1.

Asian Symposium on Advancement in Hematology and Oncology

2.

Asian Symposium on Advancement in Hematology and Oncology

1.

The Reign of the CROWN Trial and the Dawn of a New Era in Frontline Management

2.

The Comprehensive Impact of CDK4/6 Inhibition in HR+/HER2- Metastatic Breast Cancer: Insights from PALOMA-2.

3.

Navigating the Complexities of Ph Negative ALL - Part VI

4.

Virtual Case Study on Elephantiasis of Lower Limb- An Initiative by Hidoc Dr.

5.

Optimizing Treatment Options in Advanced Urothelial Carcinoma

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot